Huanjun Yang

1.8k total citations
14 papers, 204 citations indexed

About

Huanjun Yang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Huanjun Yang has authored 14 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 4 papers in Oncology. Recurrent topics in Huanjun Yang's work include Lung Cancer Diagnosis and Treatment (8 papers), Esophageal Cancer Research and Treatment (6 papers) and Gastric Cancer Management and Outcomes (4 papers). Huanjun Yang is often cited by papers focused on Lung Cancer Diagnosis and Treatment (8 papers), Esophageal Cancer Research and Treatment (6 papers) and Gastric Cancer Management and Outcomes (4 papers). Huanjun Yang collaborates with scholars based in China. Huanjun Yang's co-authors include Kailiang Wu, Lijuan Wang, Guoliang Jiang, Qian Hao, Kuaile Zhao, Shen Zhao, Xiaolong Fu, Min Fan, Xiaolong Fu and Zhengfei Zhu and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Huanjun Yang

13 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huanjun Yang China 6 146 79 67 39 38 14 204
S. Danhier France 9 165 1.1× 101 1.3× 52 0.8× 60 1.5× 59 1.6× 20 230
Maja Guberina Germany 9 168 1.2× 59 0.7× 62 0.9× 112 2.9× 23 0.6× 43 256
Soon Huh United States 10 243 1.7× 94 1.2× 166 2.5× 40 1.0× 57 1.5× 20 325
Manon Kissel France 10 82 0.6× 62 0.8× 57 0.9× 41 1.1× 93 2.4× 33 265
Elizabeth H. Baldini United States 6 228 1.6× 127 1.6× 65 1.0× 141 3.6× 44 1.2× 7 361
Joanna Socha Poland 10 126 0.9× 120 1.5× 35 0.5× 55 1.4× 77 2.0× 40 237
Sandra L Teichman United States 7 171 1.2× 30 0.4× 134 2.0× 69 1.8× 52 1.4× 9 299
Nick P Rowell United Kingdom 5 159 1.1× 67 0.8× 45 0.7× 37 0.9× 17 0.4× 5 199
Archi Agarwal India 6 198 1.4× 30 0.4× 98 1.5× 41 1.1× 50 1.3× 15 260

Countries citing papers authored by Huanjun Yang

Since Specialization
Citations

This map shows the geographic impact of Huanjun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanjun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanjun Yang more than expected).

Fields of papers citing papers by Huanjun Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huanjun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanjun Yang. The network helps show where Huanjun Yang may publish in the future.

Co-authorship network of co-authors of Huanjun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Huanjun Yang. A scholar is included among the top collaborators of Huanjun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huanjun Yang. Huanjun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Xu, Yi, Xingwen Fan, Ming Fan, et al.. (2024). Long‐term outcome of definitive radiotherapy for locally advanced non‐small cell lung cancer: A real‐world single‐center study in the pre‐durvalumab era. Cancer Medicine. 13(15). e70051–e70051. 1 indexed citations
2.
Liu, Qi, Junqiang Chen, Lin Yu, et al.. (2023). Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial. ˜The œLancet. Gastroenterology & hepatology. 9(1). 45–55. 28 indexed citations
3.
Zhang, Xiaofei, Peiyi Liu, Di Liu, et al.. (2022). Treatment outcomes of 156 patients with cervical esophageal cancers treated with definitive radiation therapy- A single-institution experience of a rare cancer. Frontiers in Oncology. 12. 929583–929583. 2 indexed citations
4.
Chen, Shuyi, Yabiao Gao, Ping Zhu, et al.. (2022). Anti-cancer Drug Anlotinib Promotes Autophagy and Apoptosis in Breast Cancer. Frontiers in Bioscience-Landmark. 27(4). 125–125. 11 indexed citations
5.
Ai, Dashan, Yun Chen, Qi Liu, et al.. (2021). The Prognosis and Feasibility of Extensive Clinical Target Volume in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial. Frontiers in Oncology. 11. 669575–669575. 3 indexed citations
6.
Liu, Qi, Junqiang Chen, Baosheng Li, et al.. (2021). Local Therapy for Oligometastatic Esophageal Squamous Cell Carcinoma: A Prospective, Randomized, Phase II Clinical Trial. Future Oncology. 17(11). 1285–1293. 4 indexed citations
7.
Ai, Dashan, Jinjun Ye, Yun Chen, et al.. (2020). Final results of a phase III randomized trial of comparison of three paclitaxel-based regimens concurrent with radiotherapy for patients with local advanced esophageal squamous cell carcinoma.. Journal of Clinical Oncology. 38(15_suppl). 4564–4564. 1 indexed citations
8.
Xia, Bing, Lingzhi Hong, Xu‐Wei Cai, et al.. (2014). Phase 2 Study of Accelerated Hypofractionated Thoracic Radiation Therapy and Concurrent Chemotherapy in Patients With Limited-Stage Small-Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 91(3). 517–523. 30 indexed citations
9.
Yang, Hong, Jianhua Fu, Mengzhong Liu, et al.. (2014). A phase III clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus.. Journal of Clinical Oncology. 32(15_suppl). TPS4146–TPS4146. 1 indexed citations
10.
Xu, Zhiyong, et al.. (2011). Application of dose heterogeneity in the target volume in intensity-modulated radiation therapy of esophageal cancer. Zhonghua fangshe yixue yu fanghu zazhi. 31(4). 453–455.
11.
Xia, Bing, Xu‐Wei Cai, Jiandong Zhao, et al.. (2011). The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer. Radiation Oncology. 6(1). 50–50. 12 indexed citations
12.
Zhu, Zhengfei, Min Fan, Kailiang Wu, et al.. (2011). A phase II trial of accelerated hypofractionated three-dimensional conformal radiation therapy in locally advanced non-small cell lung cancer. Radiotherapy and Oncology. 98(3). 304–308. 36 indexed citations
13.
Li, Xiufen, et al.. (2004). [Snow/wind damage in natural secondary forests in Liaodong mountainous regions of Liaoning Province].. PubMed. 15(6). 941–6. 5 indexed citations
14.
Wu, Kailiang, Guoliang Jiang, Qian Hao, et al.. (2003). Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: A prospective phase I–II clinical trial. International Journal of Radiation Oncology*Biology*Physics. 57(5). 1345–1350. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026